CEO’s Christmas Greetings 2025

As we approach the end of 2025 and prepare to slow down for the holidays, I want to take a moment to reflect on an exceptional year for Medaffcon—one defined by growth and expansion.

Thanks to the dedication of our talented team and the trust of our clients, the year has been nothing short of record-breaking. While numbers alone never tell the full story, they do reflect the value we continue to create in the Nordics through science, insight, and collaboration.

Strengthening Our Role in the Life Science Community

One of the defining milestones of the year was Medaffcon joining the Pharma Industry Finland (PIF) community. We are honored to have had Jarmo Hahl elected to the PIF Board, marking an important step in deepening our influence on the future of the pharmaceutical ecosystem in Finland. This recognition reinforces our long-standing commitment to evidence-based decision-making, responsible use of real-world data, and advancing patient access to impactful treatments.

Scientific Contributions and Thought Leadership

In 2025, we also reached a new level in scientific output and visibility:

• Our team produced more than 20 publications, showcasing the breadth of our expertise across therapeutic and methodological areas.
• We delivered a record number of access and pricing & reimbursement projects.
• Medaffcon presented its first CORE-based posters at ISPOR, a major milestone in bringing our own data assets into global scientific dialogue.
• We strengthened our involvement in the ISPOR Nordic Chapter, taking an active role in shaping discussions on health economics, outcomes research, and the future of value-based healthcare in our region.

These achievements reflect the exceptional scientific professionalism our teams bring to every partnership.

Growing Internationally and Expanding Our Impact

This year also marked the launch of our first international EMMA event—a proud moment for our entire organization. While we see opportunities for fine-tuning the newly international concept, the positive reception and strong participation reaffirm our belief in the long-term value and possibilities of this platform.

Our Swedish team continued its strong growth as well, thriving in the inspiring environment of Forskaren, Stockholm’s hub for health innovation. The enthusiasm and momentum within the Swedish organization signal a bright future for our Nordic footprint.

Looking Ahead

As we enter 2026, our mission remains unchanged: to deliver high-quality scientific insight that enables better decisions, better care, and better outcomes. But this year has expanded our horizons—we are thinking bigger, contributing more boldly, and growing faster than ever before.